Oncologic Outcomes of Incidental Versus Biopsy-diagnosed Grade Group 1 Prostate Cancer: A Multi-institutional Study

Background and objective: Patients diagnosed with grade group (GG) 1 prostate cancer (PCa) following treatment for benign disease (“incidental” PCa) are typically managed with active surveillance (AS). It is not known how their outcomes compare with those observed in patients diagnosed with GG1 on b...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Riccardo Leni, Emily A. Vertosick, Roderick C.N. van den Bergh, Timo F.W. Soeterik, Joris G. Heetman, Harm H.E. van Melick, Marco Roscigno, Giovanni La Croce, Luigi F. Da Pozzo, Jonathan Olivier, Fabio Zattoni, Matteo Facco, Fabrizio Dal Moro, Peter K.F. Chiu, Xiaobo Wu, Isabel Heidegger, Giulia Giannini, Lorenzo Bianchi, Luca Lampariello, Leonardo Quarta, Andrea Salonia, Francesco Montorsi, Alberto Briganti, Umberto Capitanio, Sigrid V. Carlsson, Andrew J. Vickers, Giorgio Gandaglia
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Elsevier 2024-10-01
Sarja:	European Urology Open Science
Aiheet:	Active surveillance Incidental prostate cancer Surveillance biopsies Metastases
Linkit:	http://www.sciencedirect.com/science/article/pii/S2666168324006207
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!